The present invention provides the use of a metal ion chelating agent for the manufacture of a medicament for the treatment or prophylaxis of a bacteria-mediated cancerous tumour, wherein said metal ion chelating agent provides a metal ion chelating capacity for at least one metal ion on which said tumorigenic bacteria is dependent for viability. The invention also provides methods for the treatment or prophylaxis of tumours.
